Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Third. by Cuicui Liu (1496260)

Posttreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Validation of child labor measures using third-party data, households with all children in school. by Guilherme Lichand (11410286)

Superimposition of the cephalometric tracings obtained before and after treatment of case with mandibular third molar extraction. by Lijuan Liu (136685)

Comparison of pretreatment cephalometric variables between premolar extraction and mandibular third molar extraction groups. by Lijuan Liu (136685)

Comparison of upper and lower arch crowding between premolar extraction group and the mandibular third molar extraction groups. by Lijuan Liu (136685)

Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Dynamics of net spillage in the third stage (post epidemic). by Cuicui Liu (1496260)

Changes in total spillage during the third stage (post epidemic). by Cuicui Liu (1496260)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”

Training-induced changes in bipedal stance. by Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS. by Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. by Cristina Dolciotti (16317330)

Dynamics of pairwise net spillovers between sectors in the third stage (post epidemic). by Cuicui Liu (1496260)

Box plot show differences between different groups of postoperative drainage on the third day. by Na Wang (193263)

Box plot show differences between different groups of NRS score on the third day. by Na Wang (193263)